NCT01937754View on ClinicalTrials.gov

Study of the Effects of an Oral Nitric Oxide Supplement on Blood Pressure in Prehypertensive Adults

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

September 30, 2013

Conditions
Prehypertension
Interventions
DIETARY_SUPPLEMENT

Nitric Oxide supplement

Lozenge consisting of beetroot and 75 mg caffeine

DIETARY_SUPPLEMENT

Placebo

Same form factor and flavor as test lozenge but contains no active ingredients

Trial Locations (1)

90211

California Medical Institute, Beverly Hills

Sponsors
All Listed Sponsors
lead

Neogenis Laboratories

OTHER

NCT01937754 - Study of the Effects of an Oral Nitric Oxide Supplement on Blood Pressure in Prehypertensive Adults | Biotech Hunter | Biotech Hunter